We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

MAST GROUP

Mast Group is an independent manufacturer and supplier of diagnostic products for clinical, industrial and veterinary... read more Featured Products: More products

Download Mobile App





Mast Group Introduces New MAST CARBA PAcE for Rapid Carbapenemase Detection

By LabMedica International staff writers
Posted on 21 Nov 2019
Print article
Image: MAST® CARBA PAcE (Photo courtesy of Mast Group Ltd.)
Image: MAST® CARBA PAcE (Photo courtesy of Mast Group Ltd.)
Mast Group Ltd. (Liverpool, UK) was amongst the 4,500 exhibitors from 70 countries that presented their products and services at the MEDICA 2019 Trade Fair held in Düsseldorf, Germany from 18-21st November. MEDICA is the world's largest medical trade fair for medical technology, electromedical equipment, laboratory equipment, diagnostics and pharmaceuticals. MEDICA provides the medical device industry with a central market for innovative products and systems that result in an important contribution to the efficiency and quality of patient care. The combination of product shows with international congresses, forums, as well as expert workshops, and the exchange of professional views make MEDICA a meeting point for international professionals from various fields in the medical sector.

Mast is a manufacturer and supplier of diagnostic products for clinical, industrial and veterinary testing. The company manufactures microbiology and molecular biology products, as well as other infectious disease and autoimmune diagnostics, using a variety of technologies. At the 2019 edition of MEDICA, Mast introduced the new MAST CARBA PAcE for rapid carbapenemase detection in Pseudomonas spp., Acinetobacter spp. and Enterobacterales.

The company’s MAST ASSURE and CRYOBANK range also featured on the booth this year alongside its extensive range of MASTDISCS for antimicrobial susceptibility and resistance marker testing. MAST ASSURE’s extensive range contains both polyvalent and monovalent diagnostic antisera for the identification of Salmonella spp according to the expression of somatic antigens. Bacterial serotype can be determined by both slide agglutination and test tube agglutination methods.

The company’s MASTDISCS AST is available as an extensive range of antibiotic susceptibility test discs. Mast also offers an extensive range of MASTDISCS Combi antibiotic resistance detection sets for identification and differentiation of enzyme types using a combination disc technology, incorporating specific inhibitors to accurately detect extended spectrum ß-lactamase (ESßL), AmpC cephalosporinase, Metallo ß-lactamase (MBL) including VIM, IMP and NDM Klebsiella pneumoniae carbapenemase (KPC) and OXA-48 like carbapenemases.

Related Links:
Mast Group Ltd.

New
Gold Supplier
Colon Cancer Mutation Panel
UltraSEEK Colon Panel
New
Radiotherapy Toxicity Measurement Assay
Radiotherapy Toxicity Measurement Assay
New
Dengue IgG Test
Chorus Dengue IgG
New
Thyroglobulin (Tg) Assay
LIAISON Anti-Tg

Print article

Channels

Clinical Chem.

view channel
Image: Brief schematic diagram of the detection principle and method (Photo courtesy of CAS)

Rapid, Non-Invasive Method Diagnoses Type 2 Diabetes by Sniffing Urinary Acetone

Over 90% of diabetes cases are attributed to Type 2 diabetes (T2D), a prevalent metabolic condition that is expected to impact 380 million individuals globally by 2025. Despite being highly accurate, the... Read more

Molecular Diagnostics

view channel
Image: Researchers have identified the origin of subset of autoantibodies that worsen lupus (Photo courtesy of Pexels)

Lupus Biomarker Testing Could Help Identify Patients That Need Early and Aggressive Treatment

Systemic lupus erythematosus (SLE) is an autoimmune disease that occurs when the body's antibodies, which usually protect against infections, attack healthy cells and proteins. These autoantibodies can... Read more

Immunology

view channel
Image: A genetic test could guide the use of cancer chemotherapy (Photo courtesy of Pexels)

Genetic Test Predicts Whether Bowel Cancer Patients Can Benefit From Chemotherapy

Late-stage bowel cancer patients usually undergo a series of chemotherapies and targeted medicines for cancer treatment. However, the responses to the last-line chemotherapy treatment trifluridine/tipiracil... Read more

Microbiology

view channel
Image: Use of DBS samples can break barriers in hepatitis C diagnosis and treatment for populations at risk (Photo courtesy of Pexels)

DBS-Based Assay Effective in Hepatitis C Diagnosis and Treatment for At Risk Populations

In a bid to eliminate viral hepatitis as a public health threat by 2030, the World Health Organization (WHO) has put forth a proposed strategy. To this end, researchers at the Germans Trias i Pujol Research... Read more

Pathology

view channel
Image: New research has opened a path for fast and accurate cancer diagnosis (Photo courtesy of Imagene)

AI-Based Image Analysis Software Profiles Cancer Biomarkers in Real Time

Lung cancer is the most widespread type of cancer worldwide, resulting in approximately 1.76 million fatalities annually. Non-small cell lung cancer (NSCLC) accounts for 85% of all lung cancer diagnoses... Read more

Technology

view channel
Image: Live view of non-fluorescent specimens using the glowscope frame (Photo courtesy of Winona State University)

Device Converts Smartphone into Fluorescence Microscope for Just USD 50

Fluorescence microscopes are utilized to examine specimens labeled with fluorescent stains or expressing fluorescent proteins, like those tagged with green fluorescent protein. However, since these microscopes... Read more

Industry

view channel
Image: The global antimicrobial resistance diagnostics market size is expected to reach USD 5.7 billion by 2028 (Photo courtesy of Pexels)

Global Antimicrobial Resistance Diagnostics Market Driven by Increasing Hospital-Acquired Infections

Antimicrobial drugs are intended to counteract the harmful effects of microbes and promote a healthy life. However, their excessive use can result in the development of resistance, commonly referred to... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.